• 1
    Boukhris R, Becker KL 1972 Calcification of the aorta and osteoporosis. JAMA 219:13071311.
  • 2
    Frye MA, Melton LJ, Bryant SC, Fitzpatrick LA, Wahner HW, Schwartz RS, Riggs BL 1992 Osteoporosis and calcification of the aorta. Bone Miner 19:185194.
  • 3
    Riggs BL, Melton LJ 1992 The prevention and treatment of osteoporosis. N Engl J Med 329:620627.
  • 4
    von der Recke P, Hansen MA, Hassager C 1999 The association between low bone mass at the menopause and cardiovascular mortality. Am J Med 106:273278.
  • 5
    Browner WS, Seeley DG, Vogt TM, Cummings SR 1991 Nontrauma mortality in elderly women with low bone mineral density. Lancet 338:355358.
  • 6
    Naito S, Ito M, Sekine I, Ito M, Hirano T, Iwasaki K, Niwa M 1993 Femoral head necrosis and osteopenia in stroke-prone spontaneously hypertensive rats (SHRSPs). Bone 14:745753.
  • 7
    Jie KG, Bots ML, Vermeer C, Witteman JC, Grobbee DE 1996 Vitamin K status and bone mass in women with and without aortic atherosclerosis: A population-based study. Calcif Tissue Int 59:352356.
  • 8
    Barengolts EI, Berman M, Kukreja SC, Kouznetsova T, Lin C, Chomka EV 1998 Osteoporosis and coronary atherosclerosis in asymptomatic postmenopausal women. Calcif Tissue Int 62:209213.
  • 9
    Ouchi Y, Akishita M, deSouza AC, Nakamura T, Orimo H 1993 Age-related loss of bone mass and aortic/aortic valve calcification—reevaluation of recommended dietary allowance of calcium in the elderly. Ann NY Acad Sci 676:297307.
  • 10
    Laroche M, Pouilles JM, Ribot C, Bendayan P, Bernard J, Boccalon H, Mazieres B 1994 Comparison of the bone mineral content of the lower limbs in men with ischaemic atherosclerotic disease. Clin Rheumatol 13:6164.
  • 11
    Laroche M, Moulinier L, Bon E, Cantagrel A, Mazieres B 1994 Renal tubular disorders and arteriopathy of the lower limbs: Risk factors for osteoporosis in men? Osteoporos Int 4:309313.
  • 12
    Pinals RS, Jabbs JM 1972 Type-IV hyperlipoproteinemia and transient osteoporosis. Lancet 2:929.
  • 13
    Broulik PD, Kapitola J 1993 Interrelations between body weight, cigarette smoking and spine mineral density in osteoporotic Czech women. Endocr Reg 27:5760.
  • 14
    Yla-Hertualla S 1998 Is oxidized low density lipoprotein present in vivo? Curr Opin Lipidol 9:337344.
  • 15
    Watson AD, Leitinger N, Navab M, Faull KF, Horkko S, Witztum JL, Palinski W, Schwenke D, Salomon RG, Sha W, Subbanagounder G, Fogelman AM, Berliner JA 1997 Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte-endothelial interactions and evidence for their presence in vivo. J Biol Chem 272:1359713607.
  • 16
    Haberland ME, Fong D, Cheng L 1988 Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science 241:215218.
  • 17
    Morrow JD, Minton TA, Mukundan CR, Campbell MD, Zackert WE, Daniel VC, Badr KF, Blair IA, Roberts LJ 1994 Free radical-induced generation of isoprostanes in vivo. Evidence for the formation of D-ring and E-ring isoprostanes. J Biol Chem 269:43174326.
  • 18
    Rosenfeld ME, Khoo JC, Miller E, Parthasarathy S, Palinski W, Witztum JL 1991 Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts. J Clin Invest 87:9099.
  • 19
    Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ 1995 Atherosclerosis: Basic mechanisms. Oxidation, inflammation, and genetics. Circulation 91:24882496.
  • 20
    Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD, Tintut Y, Berliner JA, Demer LL 1997 Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol 17:680687.
  • 21
    Parhami F, Jackson SM, Tintut Y, Le V, Balucan JP, Territo MC, Demer LL 1999 Atherogenic diet and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic differentiation of marrow stromal cells. J Bone Miner Res 14:20672078.
  • 22
    Mullender MG, van der Meer DD, Huiskes R, Lips PP 1996 Osteocyte density changes in aging and osteoporosis. Bone 18:109113.
  • 23
    Bergman RJ, Gazit D, Kahn AJ, Gruber H, McDougall S, Hahn TJ 1996 Age-related changes in osteogenic stem cells in mice. J Bone Miner Res 11:568577.
  • 24
    Paigen B, Morrow A, Brandon C, Mitchell D, Holmes P 1985 Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis 57:6573.
  • 25
    Paigen B, Mitchell D, Reue K, Morrow A, Lusis AJ, LeBoeuf RC 1987 Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice. Proc Natl Acad Sci USA 84:37633767.
  • 26
    Liao F, Andalibi A, de Beer FC, Fogelman AM, Lusis AJ 1993 Genetic control of inflammatory gene induction and NF-kB-like transcription factor activation in response to an atherogenic diet in mice. J Clin Invest 91:25722579.
  • 27
    Navab M, Levy-Hama S, Van Lenten BJ, Fonarow GC, Cardinez CJ, Castellani LW, Brennan ML, Lusis AJ, Fogelman AM 1997 Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio. J Clin Invest 99:20052019.
  • 28
    Shih DM, Gu L, Hama S, Xia YR, Navab M, Fogelman AM, Lusis AJ 1996 Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model. J Clin Invest 97:16301639.
  • 29
    Maniotopoulos C, Sodek J, Melcher A 1988 Bone formation in vitro by stromal cell obtained from bone marrow of young adult rats. Cell Tissue Res 254:317330.
  • 30
    Malaval L, Modrowski D, Gupta AK, Aubin JE 1994 Cellular expression of bone related proteins during in vitro osteogenesis in rat bone marrow stromal cultures. J Cell Physiol 158:555572.
  • 31
    Tintut Y, Parhami F, Bostrom K, Jackson SM, Demer LL 1998 Cyclic AMP stimulates osteoblast-like differentiation of calcifying vascular cells: Potential signaling pathway for vascular calcification. J Biol Chem 273:75477553.
  • 32
    Liao F, Lusis AJ, Berliner JA, Fogelman AM, Kindy M, de Beer MC, de Beer FC 1994 Serum amyloid A protein family. Differential induction by oxidized lipids in mouse strains. Arterioscler Thromb Vasc Biol 14:14751479.
  • 33
    Gordon DJ, Probstfield JL, Garrison JR, Neaton JD, Castelli WP, Knoke JD, Jacobs DR Jr, Bangdiwala S, Tyroler HA 1989 High-density lipoprotein cholesterol and cardiovascular disease: Four prospective American studies. Circulation 79:815.
  • 34
    Ramseier E 1962 Untersuchungen uber arteriosklerotische Veranderungen der Knochenarterien. Virchows Arch Path Anat 336:7786.
  • 35
    Nyssen-Behets C, Duchesne PY, Dhem A 1997 Structural changes with aging in cortical bone of the human tibia. Gerontology 43:316325.
  • 36
    Hussain MM, Mahley RW, Boyles JK, Fainaru M, Brecht WJ, Lindquist PA 1989 Chylomicron-chylomicron remnant clearance by liver and bone marrow in rabbits. J Biol Chem 264:95719582.
  • 37
    Li Y, Watkins BA 1998 Conjugated linoleic acids alter bone fatty acid composition and reduce ex vivo prostaglandin E2 biosynthesis in rats fed n-6 or n-3 fatty acids. Lipids 33:417425.
  • 38
    Lin YC, Lyle RM, Weaver CM, Teegarden D 1999 Impact of diet variables on changes in spine bone mineral density. FASEB J 13:A244. (abstract)
  • 39
    Semmler JC 1992 Risk factors for osteoporosis in men. ICCRH, Florence (abstract).
  • 40
    Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, Boyce B, Zhao M, Gutierrez G 1999 Stimulation of bone formation in vitro and in rodents by statins. Science 286:19461949.
  • 41
    Bauer DC, Mundy GR, Jamal SA, Black DM, Cauley JA, Harris F, Duong T, Cummings SR 1999 Statin use, bone mass and fracture: An analysis of two prospective studies. J Bone Miner Res 14:S179. (abstract)
  • 42
    Meier CR, Schlienger RG, Kraenzlin ME, Schlegel B, Jick H 2000 HMG-CoA reductase inhibitors and the risk of fractures. JAMA 283:32053210.
  • 43
    Wang PS, Solomon DH, Mogun H, Avorn J 2000 HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. JAMA 283:32113216.
  • 44
    Chan KA, Andrade SE, Boles M, Buist DSM, Chase GA, Donahue JG, Goodman MJ, Gurwitz JH, LaCroix AZ, Platt R 2000 Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women. Lancet 355:21852188.
  • 45
    Edwards CJ, Hart DJ, Spector D 2000 Oral statins and increased bone mineral density in postmenopausal women. Lancet 355:22182219.
  • 46
    Hamelin BA, Turgeon J 1998 Hydrophilicity/lipophilicity: Relevance for pharmacology and clinical effects of HMG-CoA reductase inhibitors. Trends Pharmacol Sci 19:138.
  • 47
    Wohl GR, Loehrke L, Watkins BA, Zernicke RF 1998 Effects of high-fat diet on mature bone mineral content, structure, and mechanical properties. Calcif Tissue Int 63:7479.
  • 48
    Lucas A, Dai E, Liu LY, Nation PN 1998 Atherosclerosis in Marek's disease virus infected hypercholesterolemic roosters is reduced by HMGCoA reductase and ACE inhibitor therapy. Cardiovasc Res 38:237246.
  • 49
    Xu H, Watkins BA, Seifert MF 1995 Vitamin E stimulates trabecular bone formation and alters epiphyseal cartilage morphometry. Calcif Tissue Int 57:293300.
  • 50
    Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA 1999 Mortality after all major types of osteoporotic fracture in men and women: An observational study. Lancet 353:878882.